GSK buys US cancer drug maker Nuvalent for $10.6bn
LONDON: GSK’s $10.6 billion takeover of a US cancer specialist is the largest biotech acquisition…
LONDON: GSK’s $10.6 billion takeover of a US cancer specialist is the largest biotech acquisition…